Axsome Therapeutics, Inc. ($AXSM)
Filing Information
| Accession Number | 0001193125-26-021377 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 24, 2026 |
| Document Date | Jan 21, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
22,500
Total Value
$1,913,775.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Jan 21, 2026 | Exercise/Conversion | 7,500 | $70.73 | $530,475.00 | 7,500 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Jan 21, 2026 | Sale | 7,500 | $184.44 | $1,383,300.00 | 0 | Direct | โ | View Details | |
Chief Commercial Officer | Stock Option (Right to Buy) | Derivative | Jan 21, 2026 | Exercise/Conversion | 7,500 | $0.00 | $0.00 | 31,210 | Direct | โ | View Details |